Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Characterising viral clearance kinetics in acute influenza
Phrutsamon Wongnak, Timothy Seers, Podjanee Jittamala, Mallika Imwong, William HK Schilling, James A Watson, Sir Nicholas White (2025). Characterising viral clearance kinetics in acute influenza. medRxiv (Cold Spring Harbor Laboratory), DOI: 10.1101/2025.03.07.25323547.
Preprint302 days agoAntiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19
William HK Schilling, Podjanee Jittamala, Phrutsamon Wongnak, James A Watson, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M. Batty, Ellen M. Beer, Shivani Singh, Tanatchakorn Asawasriworanan, Timothy Seers, Koukeo Phommasone, Terry John Evans, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Wanassanan Madmanee, Jindarat Kouhathong, Kanokon Suwannasin, Watcharee Pagornrat, Tianrat Piteekan, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas Day, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Sir Nicholas White (2025). Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19. , DOI: https://doi.org/10.1101/2025.05.18.25327861.
Preprint231 days agoAccurate Measurement of Viral Clearance in Early-Phase Antiviral Studies in Coronavirus Disease 2019
Phrutsamon Wongnak, James A Watson, Podjanee Jittamala, William HK Schilling, Timothy Seers, Stije J. Leopold, Sir Nicholas White (2025). Accurate Measurement of Viral Clearance in Early-Phase Antiviral Studies in Coronavirus Disease 2019. , DOI: https://doi.org/10.1093/infdis/jiaf442.
Article61 days agoAntiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
William HK Schilling, Podjanee Jittamala, Phrutsamon Wongnak, James A Watson, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M. Batty, Ellen M. Beer, Shivani Singh, Tanatchakorn Asawasriworanan, Timothy Seers, Koukeo Phommasone, Terry John Evans, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Wanassanan Madmanee, Jindarat Kouhathong, Kanokon Suwannasin, Watcharee Pagornrat, Tianrat Piteekan, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas Day, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Sir Nicholas White (2025). Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial. , DOI: https://doi.org/10.1016/s1473-3099(25)00482-7.
Article61 days ago